ArticleOncoTargets and therapy2020

Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways.

Hongchao Zhen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.